Brain Death

Brain death, also called death by neurologic criteria, is the permanent loss of function of the brain as a whole, including the brainstem. Its clinical determination requires an established catastrophic brain injury, exclusion of potentially reversible explanations, and findings of coma, absent brainstem reflexes, and absence of spontaneous breathing under specified testing conditions. It is a determination of death, not simply a prediction of poor recovery, and differs from coma and other disorders of consciousness. (pmc.ncbi.nlm.nih.gov)

Mechanical ventilation can maintain oxygen delivery and allow the heart to continue beating after brain death, making the distinction between neurological death and supported bodily functions important in medicine, law, and communication with families. Brain-death determination also has implications for organ donation, although establishing death is separate from deciding whether donation will occur. International guidance describes shared clinical principles, while national standards differ in terminology, examination requirements, ancillary testing, and legal arrangements. (nhsinform.scot)

Definition and distinctions from other neurological states

Brain death, also termed death by neurologic criteria (BD/DNC), is the determination that a person has died because of permanent loss of brain function, rather than a description of exceptionally severe disability. The 2020 World Brain Death Project, led by David M. Greer and colleagues, describes the clinical state through three cardinal findings: unresponsive coma, absence of brainstem reflexes, and absence of spontaneous breathing despite an adequate respiratory stimulus. These findings establish death only when the cause of catastrophic brain injury is known and potentially reversible explanations have been excluded. In this context, permanent means that function will not resume spontaneously and will not be restored through intervention. (jamanetwork.com)

Determining death is distinct from neurological prognostication. Prognostication estimates a living patient’s future survival, recovery of consciousness, or functional abilities; BD/DNC determines whether death has already occurred. A prediction that meaningful recovery is extremely unlikely does not itself establish brain death. Neither profound unresponsiveness nor dependence on mechanical ventilation is sufficient: the required neurological findings and prerequisites must be satisfied. Conversely, a valid determination of BD/DNC is not a prediction that the patient will subsequently die when support is withdrawn. (pmc.ncbi.nlm.nih.gov)

National formulations differ in their wording and conceptual emphasis. In the United States, the 2023 multisociety guideline interprets loss of all functions of the entire brain, including the brainstem, as permanent loss of function of the brain as a whole, manifested by coma, brainstem areflexia, and apnea. It does not require proof that every neuron has ceased functioning; some neuroendocrine activity can persist. The United Kingdom’s 2025 Code of Practice defines death through permanent loss of the capacities for consciousness and breathing, resulting from permanent cessation of brainstem function. Whole-brain and brainstem-based formulations therefore converge on important clinical findings but are not interchangeable definitions; determination follows the applicable national standard. (pmc.ncbi.nlm.nih.gov)

Coma is a state without wakefulness or behavioral evidence of awareness: the eyes remain closed and the person cannot be aroused. Coma alone does not imply permanent loss of brainstem function or respiratory drive. Unresponsive wakefulness syndrome, also called the vegetative state, differs because spontaneous eye opening and sleep–wake cycles occur, although there is no behavioral evidence of awareness of self or environment. These patients retain brainstem functions, including the capacity to breathe, and are not brain dead. The distinction is thus not simply the apparent depth or duration of unconsciousness. (cdn-links.lww.com)

In the minimally conscious state, there is definite, although often inconsistent, behavioral evidence of awareness. Examples include following a simple command, visually pursuing a moving object, or producing intelligible words. Such responses distinguish this condition from unresponsive wakefulness syndrome and are incompatible with brain death. The 2018 American Academy of Neurology–led guideline emphasizes repeated standardized assessments because fluctuations in arousal, sensory deficits, and severe motor impairment can obscure evidence of consciousness. (cdn-links.lww.com)

Locked-in syndrome is primarily a disorder of motor output rather than consciousness. In its classical form, a person remains awake and aware but cannot speak or move the limbs; preserved vertical eye movements or blinking may permit communication. A brainstem stroke is one possible cause. The absence of speech and limb movement can therefore conceal preserved awareness, whereas brain death requires permanent loss of the brain functions necessary for consciousness together with the specified brainstem and respiratory findings. (rarediseases.info.nih.gov)

Causes and physiological mechanisms

Catastrophic injuries capable of causing brain death include severe traumatic brain injury, intracranial hemorrhage, extensive ischemic stroke, and global hypoxic–ischemic injury after cardiac arrest. Hemorrhagic causes include intracerebral hemorrhage and subarachnoid hemorrhage. These conditions can destroy tissue directly or initiate secondary injury that spreads beyond the original lesion. None inevitably produces brain death: the extent, distribution, and permanence of the resulting loss of function are decisive. The 2020 World Brain Death Project identified these as major etiological groups, while noting that their reported proportions depend on patient populations and referral practices. (cdn.jamanetwork.com)

A common pathway involves increasing brain volume within the relatively rigid skull. Hemorrhage and cerebral edema raise intracranial pressure (ICP), reducing the pressure gradient that drives blood through brain tissue. Cerebral perfusion pressure is conventionally approximated as $\mathrm{CPP} = \mathrm{MAP} - \mathrm{ICP}$, where MAP is mean arterial pressure. As ICP approaches arterial pressure, effective perfusion can fail; sufficiently elevated pressure can arrest intracranial circulation. Tissue displacement, or herniation, can additionally compress the brainstem and its vessels. Ischemia promotes further swelling, creating a cycle of falling blood flow and expanding injury. This is a frequent mechanism, not a necessary sequence in every case. (cdn.jamanetwork.com)

After cardiac arrest, the initiating problem is instead an abrupt loss of cerebral blood flow and delivery of oxygen and glucose. Failure of oxidative energy production depletes adenosine triphosphate, impairing energy-dependent membrane pumps. Ionic gradients collapse, cells depolarize, excitatory neurotransmitters are released, and intracellular calcium rises. Sodium and water accumulation produces cytotoxic swelling; subsequent vascular-barrier injury can add extracellular edema. Restoration of circulation does not immediately terminate these processes: mitochondrial dysfunction, inflammation, microvascular abnormalities, and reperfusion injury can sustain secondary damage. Gavin Perkins and colleagues’ 2024 International Liaison Committee on Resuscitation scientific statement therefore distinguishes overlapping phases of ischemic depolarization, reperfusion repolarization, postischemic dysregulation, and recovery or repair. Severe post-arrest injury can progress to permanent loss of brain function, but cardiac arrest or post-arrest coma alone does not establish brain death. (ahajournals.org)

The anatomical starting point also matters. Widespread cerebral injury may progress downward through herniation, whereas a primary posterior-fossa hemorrhage or infarction may initially damage the brainstem. Such injury can abolish responsiveness, brainstem reflexes, and breathing while some cortical function remains. Conversely, posterior-fossa swelling can obstruct cerebrospinal-fluid circulation and subsequently injure structures above the tentorium. Reflecting this distinction, the 2023 US multisociety guideline requires evidence of catastrophic supratentorial injury before initiating brain-death evaluation following a primary posterior-fossa injury. (neurology.org)

Loss of consciousness reflects disruption of cerebral networks and the ascending arousal systems connecting the upper brainstem with the forebrain. Loss of spontaneous breathing reflects failure of brainstem respiratory systems, including medullary circuits that normally generate respiratory output in response to chemical stimuli. These are failures of integrated neurological function, not evidence that every bodily cell has died simultaneously. The 2023 Canadian guideline explicitly distinguishes residual cellular activity from the functions required for consciousness and brainstem activity; ventilatory and circulatory support can continue supplying oxygen to tissues after death has been determined by neurological criteria. (cdn.jamanetwork.com)

Development of diagnostic standards

The expansion of mechanical ventilation and intensive care created the clinical circumstances in which neurological criteria for death became necessary. Artificial ventilation could maintain gas exchange after catastrophic brain injury had abolished spontaneous breathing; with continuing oxygen delivery and circulatory support, the heart could continue beating. Consequently, loss of brain function and cessation of circulation no longer necessarily occurred together. This development required standards that could distinguish permanent loss of brain function from potentially reversible unconsciousness, rather than relying exclusively on the eventual disappearance of breathing and a pulse. The 1968 Harvard report explicitly identified advances in resuscitation and supportive treatment as a reason for developing such criteria. (jamanetwork.com)

On August 5, 1968, an ad hoc Harvard Medical School committee chaired by anesthesiologist Henry K. Beecher published A Definition of Irreversible Coma in JAMA. Its proposed criteria included unresponsiveness, absence of spontaneous movement and breathing, and absent reflexes; an isoelectric electroencephalogram provided confirmatory evidence when available. The report required unchanged findings on repeat assessment at least 24 hours later and exclusion of hypothermia and central-nervous-system depressants. Its stated concerns included prolonged support of patients with permanently nonfunctioning brains and uncertainty surrounding organ transplantation. These were historical criteria, not an unchanged template for subsequent practice: later standards revised examination requirements, respiratory testing, and the role of electroencephalography. (aepol.net)

In the United Kingdom, the Conference of Medical Royal Colleges and their Faculties issued its statement Diagnosis of brain death on October 11, 1976. It established clinical criteria centred on permanent loss of brainstem function in appropriately selected, ventilated patients. A memorandum issued on January 15, 1979, explicitly identified death diagnosed by these criteria with death of the patient, rather than merely predicting subsequent cardiac arrest. Further revisions appeared in 1981, 1998, and 2008. Standardization developed incrementally: repetition of testing was described as customary in 1976, recommended in 1981, and explicitly required as two sets of tests in the 1998 Code. (bmj.com)

The 2020 World Brain Death Project, led by David M. Greer and international collaborators, sought minimum clinical standards for adults and children across different health systems. Forty-five experts participated in developing and reviewing recommendations. Its scope extended beyond the neurological examination to prerequisites, ancillary investigations, examiner training, documentation, and difficult circumstances such as extracorporeal support and prior temperature management. It was an international consensus framework intended to help countries and institutions develop or improve their standards—not a worldwide law or a replacement for jurisdiction-specific requirements. (jamanetwork.com)

Published online on October 11, 2023, the US Pediatric and Adult Brain Death/Death by Neurologic Criteria Consensus Guideline combined guidance from the American Academy of Neurology, American Academy of Pediatrics, Child Neurology Society, and Society of Critical Care Medicine. It updated the separate 2010 adult and 2011 pediatric guidelines through 85 recommendations covering prerequisites, examiner qualifications, examination, apnea testing, ancillary testing, and special circumstances. Because high-quality evidence was limited, the societies used an evidence-informed, modified Delphi consensus process. The resulting document provided a unified clinical basis for US institutional protocols, while addressing newer circumstances such as extracorporeal membrane oxygenation and targeted temperature management. (pmc.ncbi.nlm.nih.gov)

The Academy of Medical Royal Colleges published its 2025 UK Code of Practice on January 1, replacing the 2008 Code. Unlike a guideline confined to neurological determination, it covers confirmation of death through somatic, circulatory, and neurological criteria across healthcare settings. It incorporates age-specific pediatric guidance and expanded provisions for communication. Its neurological standards retain the UK’s brainstem-based approach while seeking greater alignment with international guidance. The Academy explicitly presented the revision as an evolution of established practice, not a retrospective invalidation of earlier diagnoses. (aomrc.org.uk)

Prerequisites and exclusion of reversible confounders

Evaluation requires an established catastrophic brain injury capable of causing permanent loss of brain function, not simply profound unresponsiveness. The 2023 United States multisociety guideline requires an identified mechanism and neuroimaging consistent with the injury’s cause and severity. An unexplained neurological state requires further investigation before assessment proceeds. Observation must allow sufficient time to establish permanence: for patients aged at least 24 months with acute hypoxic–ischemic brain injury, the guideline specifies a minimum of 24 hours after injury. Other observation periods depend on the injury’s pathophysiology and response to treatment, rather than a universal countdown. (pmc.ncbi.nlm.nih.gov)

Hypothermia can suppress neurological responses and delay drug elimination. Under the 2023 US guideline, core temperature must be at least 36°C; if it has been 35.5°C or lower, evaluation is deferred for at least 24 hours after rewarming to 36°C. Rewarming therefore does not immediately establish that confounding effects have disappeared. Physiological stability is also required because hypotension can suppress brain function. The same guideline specifies adult systolic blood pressure of at least 100 mm Hg and mean arterial pressure of at least 75 mm Hg, with individualized consideration of markedly different chronic baseline pressures. These are guideline-specific thresholds, not universal definitions. (pmc.ncbi.nlm.nih.gov)

Sedatives, anesthetics, opioids, and other intoxicants can produce reversible suppression resembling neurological death. The 2023 US guideline uses drug concentrations where available and otherwise requires at least five elimination half-lives, with longer intervals for factors delaying clearance. The American College of Medical Toxicology’s 2025 position statement emphasizes that five half-lives and a negative routine drug screen cannot reliably exclude every poisoning: screening panels omit substances, overdose can prolong elimination, and tissue effects may outlast measurable blood concentrations. It cites baclofen poisoning as an example, with reported coma lasting up to seven days despite a usual therapeutic half-life of approximately two to four hours. (pmc.ncbi.nlm.nih.gov)

Neuromuscular blockade is a separate confounder: absent movement or respiratory effort may reflect impaired muscle activation rather than absent brain function. The 2025 United Kingdom Code of Practice requires exclusion of blocking-drug effects and confirmation of adequate neuromuscular function using peripheral nerve stimulation or another recognized method, such as preserved deep-tendon reflexes. It also identifies severe neuromuscular disorders as potential sources of misleading findings. (aomrc.org.uk)

Severe electrolyte, glucose, acid–base, and endocrine disturbances must likewise be assessed for their contribution to coma or apnea. The 2025 UK code identifies hypoglycemia, hyperglycemic emergencies, elevated urea or ammonia, and endocrine conditions including myxedema and adrenal crisis. It specifies that brainstem-reflex testing should not proceed with blood glucose below 3.0 mmol/L and calls for endocrine assays when clinical findings raise suspicion. These requirements concern disturbances capable of materially explaining the neurological state; correction and reassessment distinguish reversible physiological suppression from findings attributable to the established brain injury. (aomrc.org.uk)

Neurological examination

The examination establishes unresponsiveness and the absence of brain-mediated motor activity and specified brainstem reflexes, after the prerequisites for assessment have been satisfied. The 2020 World Brain Death Project describes the required state as absence of arousal or awareness despite external stimulation. Assessment includes visual, auditory, tactile, and noxious stimuli, with observation for facial movement and limb responses. A brain-mediated response is incompatible with determination of death by neurological criteria. Movements generated through the spinal cord, however, must be distinguished from responses requiring brain function; complete bodily immobility is not itself the diagnostic requirement. (pubmed.ncbi.nlm.nih.gov)

The pupillary light and corneal reflexes examine different cranial nerve pathways. In the 2025 UK Code of Practice, pupillary testing assesses cranial nerves II and III: neither pupil should constrict in response to light, whether illuminated directly or through the consensual response elicited from the other eye. Corneal testing assesses cranial nerves V and VII, linking corneal sensation to eyelid closure; no eyelid movement should occur when either cornea is stimulated. Touching only the sclera does not adequately test this reflex. These are bilateral assessments, rather than observations confined to one eye. (aomrc.org.uk)

Eye-movement reflexes assess vestibular–brainstem pathways. The oculocephalic reflex normally produces compensatory eye movement when the head turns; oculovestibular testing uses a thermal stimulus in the ear to elicit eye movement. Under the 2023 US multisociety guideline, oculocephalic testing is omitted when cervical-spine or skull-base integrity is uncertain. Bilateral oculovestibular testing is required when the oculocephalic response is absent or cannot safely be assessed. Thus, these are not freely interchangeable alternatives: an untestable oculocephalic reflex does not by itself require ancillary investigation if bilateral oculovestibular responses are absent and all remaining criteria are satisfied. (pmc.ncbi.nlm.nih.gov)

The gag and cough reflexes assess additional brainstem functions, particularly medullary pathways. Gag testing looks for a response to stimulation of the posterior pharynx on both sides; cough testing looks for a response to deep tracheal stimulation. Both responses must be absent. Their assessment concerns reflex motor activity, not whether the patient can follow a command or communicate discomfort. Testing respiratory drive is a separate component of the determination and is not replaced by absent gag or cough responses. (pubmed.ncbi.nlm.nih.gov)

Physical limitations can make an apparently absent response uninterpretable. Severe facial swelling, sensory neuropathy, or neuromuscular disease can obscure motor responses. Corneal injury, previous eye surgery, marked orbital swelling, absent eyes, or anticholinergic medication can compromise pupillary assessment; ear or skull injuries may impede vestibular testing. High cervical cord injury can confound gag and cough assessment. The 2023 US guideline requires every safely assessable component to be examined and ancillary testing when a required component cannot be reliably assessed. Ancillary findings cannot override a demonstrable brain-mediated response; uncertainty about whether limb movements are spinally generated also warrants ancillary assessment. (pmc.ncbi.nlm.nih.gov)

Apnea testing

Apnea testing assesses whether an adequate carbon dioxide and acid–base stimulus produces spontaneous respiratory effort. Rising arterial carbon dioxide and the accompanying fall in pH normally stimulate functioning respiratory control systems in the medulla. The test therefore examines respiratory drive, rather than simply recording an absence of breathing during mechanical ventilation. It is interpreted only after the prerequisites for neurological determination of death have been satisfied; an absent respiratory response alone does not establish death. The 2023 US multisociety guideline explicitly incorporates both hypercarbia and acidemia into its assessment criteria. (neurology.org)

Conceptually, testing separates oxygen delivery from machine-generated ventilation. Oxygenation is supported while carbon dioxide is allowed to accumulate, and clinicians observe for spontaneous respiratory effort. Arterial blood-gas measurements establish the starting conditions and verify the eventual carbon-dioxide and pH stimulus; elapsed time or pulse oximetry cannot substitute for these measurements. Continuous monitoring of blood pressure, cardiac rhythm, and oxygen saturation addresses the risk of cardiovascular or respiratory deterioration. Accepted oxygenation approaches include techniques that preserve continuous positive airway pressure, which can help maintain lung recruitment without supplying mandatory breaths. These are monitored clinical assessments, not unobserved disconnections from life support. (cdn-links.lww.com)

Under the 2023 US AAN/AAP/CNS/SCCM guideline, a result consistent with neurological death in a patient without chronic carbon-dioxide retention requires no spontaneous respirations, arterial $pH<7.30$, arterial carbon-dioxide partial pressure $PaCO_2\geq60\ \mathrm{mmHg}$, and a rise of at least $20\ \mathrm{mmHg}$ above the pretest baseline. All these conditions must be met together. The 2025 UK Code of Practice likewise specifies an endpoint of at least $8.0\ \mathrm{kPa}$ (approximately $60\ \mathrm{mmHg}$), a rise of at least $2.7\ \mathrm{kPa}$ (approximately $20\ \mathrm{mmHg}$), and $pH<7.30$, with observation for at least five minutes. Numerical criteria belong to the named standards rather than constituting a universally interchangeable protocol. (neurology.org)

A completed test meeting those criteria differs fundamentally from an aborted or uninterpretable test. Any genuine spontaneous respiratory effort is incompatible with the required finding of absent respiratory drive. Conversely, absence of breathing before the necessary blood-gas endpoints have been demonstrated is insufficient. Testing is stopped for dangerous deterioration, including significant hypotension, progressive oxygen desaturation, or an arrhythmia causing hemodynamic instability. If interruption prevents demonstration of an adequate stimulus, the result cannot be counted as confirming apnea; subsequent assessment may involve repeat testing under safer conditions or an accepted ancillary investigation. (cdn-links.lww.com)

Chronic carbon-dioxide retention changes the relevant reference point because respiratory responsiveness may be adapted to a persistently elevated $PaCO_2$. The 2023 US guideline requires a rise of at least $20\ \mathrm{mmHg}$ above the known chronic premorbid baseline, while retaining the absolute $PaCO_2$ and pH endpoints. When chronic retention is suspected but the premorbid baseline is unknown, reaching the specified test endpoints without breathing does not remove that uncertainty: an ancillary investigation is additionally required. (neurology.org)

Ancillary investigations and their limitations

Ancillary investigations are required when the neurological examination or apnea test cannot be completed or reliably interpreted—for example, because facial injuries prevent reflex assessment or cardiopulmonary instability prevents respiratory testing. The 2023 US multisociety guideline requires clinical testing to the fullest extent possible; ancillary results cannot override demonstrated brain-mediated activity or bypass hypothermia or high sedative concentrations. (pmc.ncbi.nlm.nih.gov) The 2025 UK Code similarly states that no ancillary investigation completely replaces clinical assessment and recommends testing only when there is strong clinical suspicion that death has occurred. (aomrc.org.uk)

Cerebral perfusion investigations examine blood flow rather than directly measuring every brain function. Conventional four-vessel catheter angiography, accepted under the 2023 US guideline, uses intra-arterial contrast to assess anterior and posterior intracranial circulation. (organdonationalliance.org) Radionuclide brain perfusion scintigraphy uses radioactive tracers: technetium-99m HMPAO and ECD cross the blood–brain barrier and become retained in perfused brain tissue. Delayed images therefore assess tissue perfusion, whereas non-brain-penetrating agents principally show vascular transit. The SNMMI/EANM version 3.0 guideline emphasizes that absent intracranial uptake must be interpreted alongside adequate tracer delivery and radiopharmaceutical quality control: defective labeling can falsely suggest absent perfusion. Single-photon emission computed tomography (SPECT) improves visualization of the posterior fossa and helps separate scalp activity from intracranial uptake, although published comparisons have not established superior diagnostic accuracy over planar imaging. (sites.snmmi.org)

Transcranial Doppler ultrasonography detects cerebral circulatory arrest through characteristic oscillating flow or short systolic spikes. The 2023 US guideline accepts it in adults, not children, because pediatric validation is insufficient. Approximately 10% of adults have skull thickness preventing adequate insonation; failure to obtain a signal is not itself a diagnostic flow pattern. (organdonationalliance.org) Age limitations also affect radionuclide studies: the SNMMI/EANM guideline identifies uncertain applicability in premature and young infants and notes that tracer-validation evidence is concentrated on HMPAO rather than ECD. (sites.snmmi.org)

Electroencephalography records predominantly cerebral cortical electrical activity and does not assess brainstem function. Consequently, an electrically silent recording cannot establish the required loss of brainstem function. The 2023 US guideline no longer accepts it as an ancillary test. (organdonationalliance.org) The 2025 UK Code likewise no longer recommends EEG for this purpose in adults or children, while retaining its separate diagnostic role in detecting conditions such as non-convulsive seizures. (aomrc.org.uk)

Structural CT or MRI can establish the injury’s cause without constituting an accepted ancillary test. The 2023 US guideline excludes CT angiography, MRI, and MR angiography because validation is inadequate, including concerns about false-positive CT angiographic results. (organdonationalliance.org) Acceptance differs internationally: the 2025 UK Code references national guidance supporting cerebral CT angiography in adults. It does not recommend ancillary investigations in children younger than two years and emphasizes specialist expertise, local availability, and test-specific limitations when selecting and interpreting an investigation. (aomrc.org.uk)

Infants, children, and complex clinical circumstances

The 2023 US multisociety guideline excludes infants below 37 weeks’ corrected gestational age because immature brainstem reflexes make assessment less reliable. For children younger than 24 months, it specifies at least 48 hours after acute brain injury before evaluation begins. Pediatric determination requires two independent examinations by two clinicians, separated by at least 12 hours, and two apnea tests, one after each examination. These are separate safeguards: observation after injury establishes permanence, whereas repetition checks the clinical findings. In infants younger than six months, the examination additionally requires absence of sucking and rooting reflexes. (neurology.org)

The UK 2025 Code likewise sets the lower boundary at 37 weeks’ corrected gestation, but uses different timing requirements. From that boundary until two years’ corrected age, testing must await at least 24 hours after the last observed brainstem reflex or spontaneous breath, and the two sets of clinical tests must be separated by 24 hours. Two doctors work together through the repeated assessments. At two years, adult criteria apply. This replaced the earlier transition at two months after term under the 2008 Code and 2015 pediatric guidance; the dated standards therefore should not be treated as interchangeable. (aomrc.org.uk)

Extracorporeal membrane oxygenation (ECMO) complicates respiratory assessment because its membrane lung removes carbon dioxide independently of the patient’s lungs. Stopping ventilator breaths alone may therefore fail to produce an adequate respiratory stimulus. The 2023 US guideline addresses this through controlled modification of extracorporeal gas exchange. Venoarterial ECMO introduces another difficulty: native cardiac output and circuit blood can mix at variable locations, so a single arterial sample may not represent blood reaching the brain. The guideline requires both patient arterial and postoxygenator circuit samples to meet the carbon-dioxide and pH criteria; venovenous ECMO requires patient arterial sampling only. (organdonationalliance.org)

Isolated infratentorial injury can produce coma, absent brainstem reflexes, and apnea while supratentorial function remains. The 2023 US guideline therefore requires conventional neuroimaging evidence of catastrophic supratentorial injury before evaluation following a primary posterior-fossa lesion. The UK 2025 Code instead permits determination with isolated posterior-fossa or brainstem pathology when permanence is established, recommending MRI to delineate injury and multidisciplinary agreement about elapsed time and remaining therapeutic options. These are substantively different diagnostic frameworks, not simply different examination schedules. (organdonationalliance.org)

Suspected high cervical spinal cord injury presents a separate problem: absent respiratory movement may reflect interruption of motor pathways rather than loss of brainstem respiratory drive. The UK Code requires investigation, generally CT or MRI, and does not accept apnea testing alone when cord pathology is demonstrated. Its pediatric provisions are especially restrictive because ancillary investigations are not recommended below two years. Evidence limitations also affect older children: the US guideline rejects transcranial Doppler ultrasonography as a pediatric ancillary test because it has not been validated in children. Neither neonatal eligibility nor test acceptance can therefore be inferred solely from adult practice. (aomrc.org.uk)

Supported bodily functions and spinal movements

Mechanical ventilation can maintain gas exchange after death by neurological criteria: oxygen enters the blood through the lungs even though the brain no longer generates a respiratory drive. The heart’s intrinsic electrical activity can sustain contractions without commands from the brain, provided that the heart muscle receives adequate oxygenated blood. Intravenous fluids and medicines that support blood pressure or cardiac contraction may also be required to maintain circulation and organ perfusion. A heartbeat and chest movements produced by ventilation therefore do not demonstrate retained consciousness or spontaneous breathing, and do not reverse a correctly established determination of neurological death. (gosh.nhs.uk)

The spinal cord and peripheral neuromuscular apparatus can remain functional while circulation supplies them with oxygen. Local sensory–motor circuits can produce movements without signals passing through the brain; loss of descending control can also allow spinal reflexes and automatisms to emerge. Examples include plantar responses, abdominal reflexes, isolated limb jerks, and the triple-flexion response of a leg. Such movements may be elicited by stimulation or occur spontaneously, sometimes first appearing after an initial period of flaccid paralysis. Their occurrence after the determination of death is not, by itself, evidence that brain function has returned. (nhsbtdbe.blob.core.windows.net)

The Lazarus sign is a particularly striking complex movement, typically involving bilateral arm flexion with the hands moving toward the chest or face, sometimes followed by the arms falling across the chest. It can resemble a purposeful gesture but is classified as a spinally mediated motor pattern rather than a response demonstrating awareness. Reported triggers include passive neck movement, stimulation, and interruption of ventilation. In a 2006 prospective study by Suk-Geun Han and colleagues, 5 of 26 patients meeting brain-death criteria—19.2%—displayed reflex movements; the observed patterns included the Lazarus sign, abdominal and flexion reflexes, and periodic leg movements. This small series documents their occurrence rather than establishing a universal prevalence. (onlinelibrary.wiley.com)

Not every movement can safely be assumed to originate in the spinal cord. Brain-mediated motor responses are incompatible with the diagnosis, and uncertain movements require further diagnostic assessment. The 2025 UK Code of Practice distinguishes spinal or neuromuscular movements from evidence of brainstem function and identifies ancillary investigation as a means of resolving uncertainty about their origin. It also distinguishes genuine respiratory effort from ventilator auto-triggering, in which a machine delivers breaths without a brain-generated inspiratory effort. Neither the visual complexity of a limb movement nor the appearance of a ventilator-delivered breath alone establishes its neurological origin. (aomrc.org.uk)

Residual hormone secretion requires similarly specific interpretation. The 2023 US multisociety guideline states that hypothalamic–pituitary function may persist, partly because variable extracranial blood supply can protect this system from intracranial ischemia. Loss of vasopressin secretion can cause excessive urine production and disturbed water balance, but this complication does not occur in every patient meeting neurological criteria. Recommendation 39 explicitly permits determination despite evidence of neuroendocrine function. The UK’s 2025 Code likewise does not require cessation of every neurological or bodily function. Continued endocrine activity and supported organ function must therefore be interpreted under the applicable definition and diagnostic standard, rather than treated as equivalent to retained consciousness, brainstem reflexes, or respiratory drive. (pmc.ncbi.nlm.nih.gov)

Legal recognition, professional responsibility, and documentation

The 1980 Uniform Determination of Death Act (UDDA), developed by the Uniform Law Commission, is a model for US state legislation, not a federal statute. It recognizes two alternative grounds for determining death: irreversible cessation of circulatory and respiratory functions, or irreversible cessation of every function of the entire brain, including the brainstem. It also requires determination according to accepted medical standards. The model therefore states the legal threshold without prescribing individual bedside tests. Its wording must be distinguished from the provisions actually enacted in each jurisdiction. For example, Nevada Revised Statutes §451.007 expressly incorporates specified adult and pediatric professional guidelines and subsequent revisions approved by the named organizations. (uniformlaws.org)

Legal definitions, professional standards, and hospital protocols perform different roles. The definition establishes what must be demonstrated; professional guidance specifies how clinicians assess it; institutional policies organize examiner authorization, testing, and recording within applicable law. The 2023 US multisociety guideline requires attending examiners to be appropriately credentialed hospital medical staff and competent in neurological death determination. Qualifications are not internationally interchangeable: the UK Academy of Medical Royal Colleges’ 2025 Code requires at least two competent doctors, each with more than five years of full General Medical Council registration or recognized equivalent, with at least one holding consultant status. (organdonationalliance.org)

Documentation records the evidence supporting the determination, rather than merely the conclusion “brain dead.” The clinical record should identify the catastrophic injury and its established cause; fulfillment of observation and physiological prerequisites; exclusion of drug effects, hypothermia, and other reversible confounders; and findings from each required neurological examination. Respiratory-test documentation includes absence of spontaneous breathing and the relevant arterial blood-gas results, including carbon dioxide and pH. If an ancillary investigation is necessary, the record identifies its indication, result, and interpretation; an examination component that could not be assessed must not be recorded as absent. The 2023 US guideline supplies a checklist to standardize this assessment. (pmc.ncbi.nlm.nih.gov)

The recorded time of death follows the applicable standard, not a universal convention. Under the 2023 US guideline, when clinical testing establishes death, the assigned time is when results from the final apnea test are reported and demonstrate the required carbon-dioxide and pH criteria. When an ancillary test is required, it is the time an attending clinician documents that its findings are consistent with neurological death. The 2025 UK Code instead ordinarily assigns death to completion of the second set of clinical tests. If ancillary investigations follow clinical testing, it uses the point when the final two doctors are satisfied that all relevant criteria are fulfilled. This replaced the earlier UK practice of retrospectively assigning death to completion of the first test set. (pmc.ncbi.nlm.nih.gov)

Clinical determination, formal declaration or pronouncement, and completion of a death certificate are related but distinct functions. Determination establishes that diagnostic criteria are met; declaration formally records that conclusion under the applicable arrangements; certification supplies medical information for civil registration, including the causal sequence leading to death. The US National Center for Health Statistics’ 2023 handbook distinguishes the pronouncing clinician from the medical certifier, who may be a different person where state law permits. It also requires identification of the disease or injury responsible for death: recording neurological death alone does not supply the underlying etiology. Thus, the diagnostic record and the cause-of-death certificate serve different evidentiary and administrative purposes. (pmc.ncbi.nlm.nih.gov)

Organ donation, family communication, and cultural contexts

Determining death and authorizing organ donation are separate processes: a neurological determination establishes whether death has occurred, whereas donation requires its own applicable consent or authorization. Donation registration does not replace the examination or establish the diagnosis. Safeguards against conflicts of interest include separating death determination from organ recovery and recipient care. For example, New Jersey’s regulation 13:35-6A.5 excludes the examining physician from responsibility for the contemplated recovery or transplantation of the donor’s organs, from serving as the recipient’s attending physician, and from other potentially significant procurement-related conflicts. In the United Kingdom, donation authorization may derive from the person’s expressed decision, legally applicable deemed consent, or an authorized representative or qualifying relative; these are not permissions to alter the criteria for death. (njconsumeraffairs.gov)

Donation after neurological determination of death—often abbreviated DBD—takes place after death has been confirmed while ventilation and circulatory support continue to maintain organ perfusion. Donation after circulatory determination of death, or DCD, instead follows confirmation of death using circulatory criteria; it does not require a preceding diagnosis of brain death. In controlled DCD, the decision to withdraw life-sustaining treatment is distinct from the donation decision. Withdrawal precedes circulatory arrest, and death must be confirmed before organ recovery. Uncontrolled DCD follows an unexpected arrest with unsuccessful resuscitation. An international collaborative statement published in 2021 specifies that the clinician declaring circulatory death should be independent of the organ-recovery team and of clinical responsibilities toward potential recipients. (odt.nhs.uk)

Communication addresses both the findings establishing death and the bodily signs that can appear inconsistent with it. Explanations distinguish the ventilator’s movement of the chest and the supported heartbeat from spontaneous breathing or recovery of consciousness. Families may also witness movements originating in the spinal cord rather than the brain. The 2023 US multisociety guideline recommends informing families before evaluation, using understandable language, offering emotional support, and allowing them the option of observing the neurological examination and apnea test, with advance explanation of possible reflex movements. (odt.nhs.uk)

The UK National Institute for Health and Care Excellence guideline CG135, published in 2011, identifies trained interpreters, advocates, bereavement services, and faith representatives as possible sources of support. It calls for private, compassionate discussions and sufficient time to understand the information. Its recommended sequence is to explain neurological death or the decision to withdraw treatment before discussing donation, normally in a separate conversation unless the family raises both together. Opportunities for questions therefore concern the meaning and confirmation of death as well as donation procedures, intervening treatments, and the possibility that donation may not proceed despite authorization. The guideline also requires reassurance that care and dignity do not depend on agreement to donate. (nice.org.uk)

Accommodation arrangements concern individual beliefs rather than a presumed position shared by an entire religion or culture. New Jersey prohibits declaration by neurological criteria when the examining physician has reason to believe it would violate the patient’s personal religious beliefs; in those circumstances, death is determined solely by cardiorespiratory criteria. Separately, the 2023 US guideline supports a reasonable but limited period of continued organ support after neurological death and institutional procedures for resolving disagreements. (njconsumeraffairs.gov) NHS Blood and Transplant’s faith-and-beliefs commitment provides another documented arrangement: specialist nurses discuss possible adaptations to donation with families, help them contact their own religious authorities or pastoral carers, and seek support for those representatives to attend discussions or relevant procedures. This process establishes the individual’s wishes without treating religious affiliation itself as either authorization or refusal. (organdonation.nhs.uk)

References

1. Determination of Brain Death/Death by Neurologic Criteria: The World Brain Death Project — PubMedpubmed.ncbi.nlm.nih.gov
2. Pediatric and Adult Brain Death/Death by Neurologic Criteria Consensus Guidelinepmc.ncbi.nlm.nih.gov
3. A Code of Practice for the diagnosis and confirmation of death: 2025 updateaomrc.org.uk
4. Practice guideline update: Disorders of consciousnesscdn-links.lww.com
5. Practice guideline update recommendations summary: Disorders of consciousnesspmc.ncbi.nlm.nih.gov
6. Locked-in syndrome — GARDrarediseases.info.nih.gov
7. The Science of Brain Death/Death by Neurologic Criteria: Supplement 2 to the World Brain Death Projectcdn.jamanetwork.com
8. A brain-based definition of death and criteria for its determination after arrest of circulation or neurologic function in Canada: a 2023 clinical practice guidelinelink.springer.com
9. AAN Summary of Evidence-based Guideline for Caregivers and Families of Patientsaan.com
10. A Definition of Irreversible Coma: Report of the Ad Hoc Committee of the Harvard Medical School to Examine the Definition of Brain Deathaepol.net
11. Pediatric and Adult Brain Death/Death by Neurologic Criteria Consensus Guidelinepmc.ncbi.nlm.nih.gov
12. 2025 Code of Practice for the diagnosis and confirmation of deathaomrc.org.uk
13. ACMT Position Statement: Determining Brain Death in Adults and Children After Drug Overdoseacmt.net
14. ACMT Position Statement 2025: Determining Brain Death in Adults and Children After Drug Overdoseacmt.net
15. A Code of Practice for the Diagnosis and Confirmation of Death: 2025 Updateaomrc.org.uk
16. 2023 Brain Death Guidelinecdn-links.lww.com
17. Pediatric and Adult Brain Death/Death by Neurologic Criteria Consensus Guidelineorgandonationalliance.org
18. The SNMMI/EANM Practice Guideline for Radionuclide Brain Perfusion Scintigraphy in Suspected Death by Neurologic Criteria (Brain Death) 3.0sites.snmmi.org
19. Understanding brain stem deathgosh.nhs.uk
20. MPD/nhsbtdbe.blob.core.windows.net
21. Reflex movements in patients with brain death: a prospective study in a tertiary medical centerpubmed.ncbi.nlm.nih.gov
22. Reflex Movements in Patients with Brain Deathjkms.org
23. 1980 Uniform Determination of Death Actuniformlaws.org
24. NRS: Chapter 451—Dead Bodiesleg.state.nv.us
25. Physician’s Handbook on Medical Certification of Deathcdc.gov
26. NEW JERSEY REGISTER: Declarations of Death upon the Basis of Neurological Criterianjconsumeraffairs.gov
27. Glossary of Terms for Deceased Organ and Tissue Donation and Transplantationodt.nhs.uk
28. Expanding controlled donation after the circulatory determination of death: statement from an international collaborativepmc.ncbi.nlm.nih.gov
29. Organ donation for transplantation: improving donor identification and consent rates for deceased organ donation—Recommendationsnice.org.uk
30. Our faith and beliefs commitmentorgandonation.nhs.uk